Policymakers have embraced pay-for-performance and shared savings/risk models to improve healthcare and moderate cost growth in publically funded healthcare programs. There is a strong commitment by both public and private payers to move from volume-based payment toward payment models rewarding value. The Affordable Care Act authorized Medicare to contract with accountable care organizations (ACOs), networks of providers responsible for the health care of a defined population. While implementation of these programs is moving forward rapidly, there is little evidence to guide whether these programs have the potential to yield real cost savings while improving quality. Under the R21 phase of this application, we will complete an evaluation of Medicare's Physician Group Practice Demonstration, a joint pay-for-performance and shared savings effort in 10 multi-specialty physician groups. The Physician Group Practice Demonstration reforms are similar in many respects to the currently legislated ACO reforms, and thus qualify as the best evidence we have to date of the effects of ACO incentives. Yet beyond bonus payments and quality scores publicly reported for each of the ten sites, little is known about how the incentive scheme affected overall costs, quality or outcomes. Our data analysis begins with a simple difference-in-difference strategy, with local Medicare beneficiaries as controls, to measure the effect of the Demonstration on Medicare payments and quality metrics beyond those measured for payment purposes. We will expand the comparison groups to similar physician practices beyond local controls and will focus on accounting for selection into the program and the role of risk adjustment in study of costs and outcomes. In addition, a major objective of our research will be to develop a structural model of Medicare payment reform incentive schemes, with parameters estimated using outcomes arising from the Physician Group Practice Demonstration, that we believe can explain some part of the heterogeneity observed in provider responses to the PGPD. The milestones for completion of the R21 phase will include development of a theoretical model of ACO incentive schemes, completion of appropriate control groups and estimation of a selection model, specification of appropriate quality and outcome measures, and adequate risk adjustment measures. In the R33 phase of the application, we will apply techniques and models developed in the R21 phase to the Pioneer and Medicare Shared Savings Programs, which will include a greater number of accountable care organization participants and more subtleties in incentive design.

Public Health Relevance

Public and private payers are moving towards payment systems with pay-for-performance, shared savings, and risk incentives, yet little is known about how these programs affect the cost or outcomes for patients. The importance of our proposed research is to help policymakers design and prioritize their efforts in payment reform to reduce cost growth and protect against adverse consequences for patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
4R33AG044251-03
Application #
8928816
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Bhattacharyya, Partha
Project Start
2012-09-30
Project End
2017-05-31
Budget Start
2014-09-30
Budget End
2015-05-31
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
City
Hanover
State
NH
Country
United States
Zip Code
03755
Ouayogodé, Mariétou H; Colla, Carrie H; Lewis, Valerie A (2016) Determinants of success in Shared Savings Programs: An analysis of ACO and market characteristics. Healthc (Amst) :
Peiris, David; Phipps-Taylor, Madeleine C; Stachowski, Courtney A et al. (2016) ACOs Holding Commercial Contracts Are Larger And More Efficient Than Noncommercial ACOs. Health Aff (Millwood) 35:1849-1856
Colla, Carrie H; Lewis, Valerie A; Tierney, Emily et al. (2016) Hospitals Participating In ACOs Tend To Be Large And Urban, Allowing Access To Capital And Data. Health Aff (Millwood) 35:431-9
Albright, Benjamin B; Lewis, Valerie A; Ross, Joseph S et al. (2016) Preventive Care Quality of Medicare Accountable Care Organizations: Associations of Organizational Characteristics With Performance. Med Care 54:326-35
Colla, Carrie H; Lewis, Valerie A; Bergquist, Savannah L et al. (2016) Accountability across the Continuum: The Participation of Postacute Care Providers in Accountable Care Organizations. Health Serv Res 51:1595-611
Colla, Carrie H; Lewis, Valerie A; Kao, Lee-Sien et al. (2016) Association Between Medicare Accountable Care Organization Implementation and Spending Among Clinically Vulnerable Beneficiaries. JAMA Intern Med 176:1167-75
Colla, Carrie H; Lewis, Valerie A; Beaulieu-Jones, Brendin R et al. (2015) Role of pharmacy services in accountable care organizations. J Manag Care Spec Pharm 21:338-44
Colla, Carrie H; Goodney, Philip P; Lewis, Valerie A et al. (2014) Implementation of a pilot accountable care organization payment model and the use of discretionary and nondiscretionary cardiovascular care. Circulation 130:1954-61
Colla, Carrie H; Lewis, Valerie A; Gottlieb, Daniel J et al. (2013) Cancer spending and accountable care organizations: Evidence from the Physician Group Practice Demonstration. Healthc (Amst) 1:100-107
Colla, Carrie H; Wennberg, David E; Meara, Ellen et al. (2012) Spending differences associated with the Medicare Physician Group Practice Demonstration. JAMA 308:1015-23